clofibrate has been researched along with transforming growth factor beta in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Austin, S; Hirose, T; Jetten, AM; Medvedev, A; Yan, ZH | 1 |
| Alvarez, AM; Cascales, M; Díez-Fernández, C; Sanz, N; Wolf, A | 1 |
| Buchmann, A; Buenemann, CL; Schmiechen, A; Schwarz, M; Stroh, C; Willy, C | 1 |
| Dixon, CL; Hebert, C; Lu, L; Rovin, BH; Wilmer, WA | 1 |
| Banfi, C; Brioschi, M; Castiglioni, L; Cimino, M; Gelosa, P; Gianella, A; Nobili, E; Pignieri, A; Sironi, L; Tremoli, E | 1 |
5 other study(ies) available for clofibrate and transforming growth factor beta
| Article | Year |
|---|---|
Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
Topics: 3T3 Cells; Adipocytes; Animals; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Line; Clofibrate; DNA-Binding Proteins; Fibroblasts; Humans; Lipoprotein Lipase; Mice; Nuclear Proteins; Nuclear Receptor Subfamily 1, Group D, Member 1; Nuclear Receptor Subfamily 1, Group F, Member 1; Nuclear Receptor Subfamily 1, Group F, Member 3; Prostaglandin D2; Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; RNA, Messenger; Stem Cells; Thiazoles; Trans-Activators; Transcription Factors; Transcriptional Activation; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 1998 |
The effect of non-genotoxic carcinogens, phenobarbital and clofibrate, on the relationship between reactive oxygen species, antioxidant enzyme expression and apoptosis.
Topics: Animals; Apoptosis; Carcinogens; Catalase; Cells, Cultured; Clofibrate; Gene Expression Regulation, Enzymologic; Liver; Male; Peroxides; Phenobarbital; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Transforming Growth Factor beta | 1998 |
Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Calcium-Calmodulin-Dependent Protein Kinases; Caspase 3; Caspases; Clofibrate; DDT; Dexamethasone; Dieldrin; Insulin; Liver Neoplasms, Experimental; NF-kappa B; Phenobarbital; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells.
Topics: Cells, Cultured; Clofibrate; Dose-Response Relationship, Drug; Genetic Vectors; Glomerular Mesangium; Humans; Hydrogen Peroxide; Immunohistochemistry; Ligands; Luciferases; Mitogen-Activated Protein Kinases; Plasmids; Promoter Regions, Genetic; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Transduction, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.
Topics: Animals; Blotting, Western; Brain; Chemokine CCL2; Clofibrate; Disease Models, Animal; Fenofibrate; Hypertension; Inflammation; Interleukin-1beta; Kidney Diseases; Ligands; Male; Oxidative Stress; PPAR alpha; Rats; Rats, Inbred SHR; Stroke; Transforming Growth Factor beta | 2010 |